Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg

Clinical Trial ID NCT00565968

PubWeight™ 1.66‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00565968

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Front Oncol 2013 0.89
2 Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies. Ther Deliv 2011 0.77
Next 100